Fusion Homoeopathics is the South African distributor of Homeovitality, a product range imported from the United Kingdom. Dr Peter Kay, a molecular pathologist, immunologist and geneticist developed the Homeovitality micro-DNA therapy system.
In 1997, Prof. Khuda-Bukhsh proposed that homoeopathic substances have the capacity to interact with the genetic blueprint and deliver their benefits by increasing the expression of genes that synthesise health promoting proteins. Since then, work by Prof. Khuda-Bukhsh and other scientists has clearly demonstrated that homoeopathic substances do have the capacity to do this.
The genetic blueprint contains many genes that promote health as well as many genes that cause disease. Drs. Jenaer and Marichal pioneered the use of highly diluted small DNA molecules with well-defined sequences to target immune response genes and fight infections. Their system, called Micro-Immunotherapy proved to be very effective. The Homeovitality system was developed along the same lines as Micro-Immunotherapy.
The Homeovitality system uses highly diluted DNA molecules with precise sequences to target genes that produce the body’s natural proteins that have been proven to promote health as well as protect against and resolve many diseases.
Homeovitality products are manufactured in compliance with standards set down by the Australian Therapeutic Goods Administration (TGA) in an Australian laboratory licensed by the Australian Department of Health, (TGA Licence no 50725) to produce medicines to a GMP standard accepted by the World Health Organisation. The gene targeting DNA molecules are prepared, purified and sequenced by the Melbourne laboratory Genetic Technologies (GTG), one of Australia’s leading and internationally recognised genetics laboratories.
Contact Fusion Homoeopathics on firstname.lastname@example.org for prices and more information about the range.